Sign in

CIK 0000944809

  • Accelerated filer

OPKO HEALTH, INC.

Sign in to watch
Ticker
OPK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
752402409
Phone
+1 305-575-4181
Business address
4400 BISCAYNE BLVD., MIAMI, FL, 33137
Former names
EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$24,577
in 1 filing

Net −$24,577. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. PAGANELLI JOHN A −$25K Director sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-07-24 Logal Adam Sr. Vice President, CFO Shares withheld for taxes −53,266 $1.22 $65K 563,396
2025-05-27 Logal Adam Sr. Vice President, CFO Grant or award · Stock Option (Right to Buy) +437,500 437,500
2024-07-24 Logal Adam Sr. Vice President, CFO Grant or award +437,500 616,662
2023-05-18 Logal Adam Sr. Vice President, CFO Grant or award · Stock Option (Right to Buy) +700,000 700,000
2021-02-19 Logal Adam Sr. Vice President, CFO Grant or award · Stock Option (Right to Buy) +350,000 350,000
2020-06-04 Logal Adam Sr. Vice President, CFO Grant or award · Stock Option (Right to Buy) +350,000 350,000
2019-07-01 Logal Adam Sr. Vice President, CFO Grant or award · Stock Option (Right to Buy) +250,000 250,000

Page 1 of 1 · 7 trades